Literature DB >> 2341523

Separation and characterization of the metabolic products of lappaconitine in rat urine by high-performance liquid chromatography.

F M Xie1, H C Wang, H L Shu, J H Li, J R Jiang, J P Chang, Y Y Hsieh.   

Abstract

The separation and characterization of the metabolic products of lappaconitine in rat urine by high-performance liquid chromatography with electrochemical and ultraviolet detection are described. Urine samples from rats intravenously administered lappaconitine hydrobromide were extracted with chloroform and then purified on a Sep-Pak C18 cartridge. The subsequent resolution into individual compounds was achieved by high-performance liquid chromatography. Identification of these compounds was based on comparisons of the chromatographic behaviour and the detector response with those of authentic samples. Changes in the ratio of lappaconitine to its metabolites in rat urine with time after dosing led to a proposal for one of the probable metabolic pathways of lappaconitine in the rat.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2341523     DOI: 10.1016/s0378-4347(00)82488-3

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

1.  Nanostructured lipid carriers for percutaneous administration of alkaloids isolated from Aconitum sinomontanum.

Authors:  Teng Guo; Yongtai Zhang; Jihui Zhao; Chunyun Zhu; Nianping Feng
Journal:  J Nanobiotechnology       Date:  2015-07-10       Impact factor: 10.435

2.  Hybrides of Alkaloid Lappaconitine with Pyrimidine Motif on the Anthranilic Acid Moiety: Design, Synthesis, and Investigation of Antinociceptive Potency.

Authors:  Kirill P Cheremnykh; Victor A Savelyev; Sergey A Borisov; Igor D Ivanov; Dmitry S Baev; Tatyana G Tolstikova; Valentin A Vavilin; Elvira E Shults
Journal:  Molecules       Date:  2020-11-27       Impact factor: 4.411

3.  Analysis of the metabolites of mesaconitine in rat blood using ultrafast liquid chromatography and electrospray ionization mass spectrometry.

Authors:  Peng Tan; Xin Chen; Ruirui He; Yonggang Liu
Journal:  Pharmacogn Mag       Date:  2014-04       Impact factor: 1.085

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.